Eric P. Palmer - 28 Feb 2024 Form 4 Insider Report for Cigna Group (CI)

Role
EVP, Enterprise Strategy and President & CEO, Evernorth Health Services
Signature
Matthew Arnold, attorney-in-fact
Issuer symbol
CI
Transactions as of
28 Feb 2024
Net transactions value
$0
Form type
4
Filing time
01 Mar 2024, 19:44:36 UTC
Previous filing
15 Feb 2024
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +5,127 +11% $0.000000 50,169 28 Feb 2024 Direct F1
holding CI Common Stock, $.01 Par Value 245 28 Feb 2024 By 401(k) F2
holding CI Common Stock, $.01 Par Value 41 28 Feb 2024 By Spouse's 401(k) F2
holding CI Common Stock, $.01 Par Value 1,437 28 Feb 2024 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +18,677 $0.000000 18,677 28 Feb 2024 Common Stock, $.01 Par Value 18,677 $336.48 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted shares vest in three equal annual installments beginning March 1, 2025.
F2 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
F3 This option vests in three equal annual installments beginning March 1, 2025.

Remarks:

EVP, Enterprise Strategy and President & CEO, Evernorth Health Services